Regeneron Pharmaceuticals, Inc. (REGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Company Overview - Regeneron is represented by its Co-Founders and Co-Chairs, President and CEO Len Schleifer, and President and CSO George Yancopoulos at the JPMorgan Conference [1] - The company has a core portfolio and an expanding pipeline, indicating a focus on growth and innovation [1] Conference Insights - The JPMorgan Conference has been a significant platform for Regeneron, with the company participating consistently over the past 37 years [3] - The phrase "promising data" has been a recurring theme in Regeneron's presentations, highlighting the company's commitment to delivering impactful results [3] Presentation Format - The presentation is structured to last approximately 20 minutes, followed by a Q&A session, allowing for direct engagement with the audience [2]